Suppr超能文献

资源有限环境下的儿童耐多药结核病与艾滋病毒合并感染:一例病例报告

Pediatric multi-drug resistant-tuberculosis and HIV co-infection in a resource-limited setting: a case report.

作者信息

Jouego Christelle Géneviève, Agbor Valirie Ndip, Noeske Juergen, Manuel Ndo Akono, Ayuk Leo Njock

机构信息

Tuberculosis Reference Laboratory Bamenda, P.O Box 586, Bamenda, Northwest Region, Cameroon.

Bamenda Regional Hospital, Northwest Region, Bamenda, Cameroon.

出版信息

BMC Res Notes. 2018 Jan 22;11(1):57. doi: 10.1186/s13104-018-3148-5.

Abstract

BACKGROUND

Tuberculosis remains a major cause of morbidity and mortality worldwide, especially in developing countries. The diagnosis and treatment of multi-drug resistant tuberculosis (MDR-TB) in children remain a major limitation in this setting, largely due to difficulties in isolating Mycobacterium tuberculosis from pediatric specimens, management with toxic second line drugs, and practically the inexistence of contact tracing. In 2016, the World Health Organization (WHO) recommended a standardized 9-month regimen for adults and children in zones which are highly endemic for the human immunodeficiency virus (HIV). Herein, we present a case of pediatric MDR-TB/HIV co-infection highlighting the difficulties in treatment and the importance of contact tracing.

CASE PRESENTATION

A 6-year old male infant from the West Region of Cameroon infected with HIV who presented at a local health center with a 10 days history of productive cough associated with nocturnal fever and abdominal pains non responsive to broad spectrum antibiotics. A sputum sample analysis requested was smear positive for acid-fast bacilli, and he was initiated on quadritherapy for drug sensitive pulmonary tuberculosis. Since he was a household contact of the mother who was being managed in a referral hospital for MDR-TB at 1 month of treatment, and given his critical clinical situation, a gastric aspirate was repeated and sent for Xpert MTB/RIF to the Tuberculosis Reference Laboratory which was positive for a Rifampicin resistant strain of M. tuberculosis. The short 9 months regimen against MDR-TB was then initiated. During the course of his management, he developed minor side effects of the drugs which were managed symptomatically.

CONCLUSION

Even though pediatric MDR-TB is difficult to confirm, it can be treated with favorable clinical outcomes using the short regimen recommended by the WHO. Experts involved in the control of tuberculosis over the national territory should consider adopting routine contact tracing for all cases of tuberculosis particularly amongst children.

摘要

背景

结核病仍然是全球发病和死亡的主要原因,尤其是在发展中国家。儿童耐多药结核病(MDR-TB)的诊断和治疗仍然是这一背景下的主要限制因素,这主要是由于从儿科标本中分离结核分枝杆菌存在困难、使用有毒二线药物进行管理以及实际上不存在接触者追踪。2016年,世界卫生组织(WHO)建议在人类免疫缺陷病毒(HIV)高度流行地区对成人和儿童采用标准化的9个月治疗方案。在此,我们报告一例儿童MDR-TB/HIV合并感染病例,突出治疗中的困难以及接触者追踪的重要性。

病例介绍

一名来自喀麦隆西部地区的6岁男婴感染了HIV,在当地卫生中心就诊,有10天的咳痰史,伴有夜间发热和腹痛,对广谱抗生素无反应。所要求的痰液样本分析显示抗酸杆菌涂片呈阳性,他开始接受针对药物敏感型肺结核的四联疗法。由于他是正在转诊医院接受MDR-TB治疗1个月的母亲的家庭接触者,且鉴于他危急的临床状况,重复进行了胃液抽吸并送往结核病参考实验室进行Xpert MTB/RIF检测,结果显示结核分枝杆菌利福平耐药菌株呈阳性。随后开始采用针对MDR-TB的9个月短程治疗方案。在治疗过程中,他出现了药物的轻微副作用,通过对症处理进行了管理。

结论

尽管儿童MDR-TB难以确诊,但使用WHO推荐的短程治疗方案可以取得良好的临床治疗效果。参与全国结核病控制的专家应考虑对所有结核病病例,尤其是儿童病例,采用常规接触者追踪。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5421/5778632/ee4ae1f6ffc0/13104_2018_3148_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验